After much controversy, the Swiss national agency for therapeutic products (Swissmedic) has approved PrenaTest, the DNA biomarker prenatal test for Down syndrome, also known as trisomy 21. The test sequences the fetal DNA circulating in the mother's blood. In June, groups representing people with Down syndrome asked the European Court of Human Rights not to recognize individuals' rights to prenatal testing for the condition, claiming that testing leads to almost universal abortions. Article